Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

Newsletter

Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.

 
 
 
   

Highlight of the week
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
151216 EFPIA Welcomes new Agreement on General Data Protection Regulation
16 December 2015
Read more


 
 
 
   

News
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
Thumbnail

160620 Pharmaceutical companies drive transparency and underline industry investment in European...
20 June 2016

Over the next ten days, pharmaceutical companies will be disclosing details of collaborations with HCPs and HCOs across... Read more
Thumbnail

151002 EFPIA welcomes Member States sharing experience on new models for patient access
02 October 2015

Vytenis Andriukaitis calls for new partnership between pharmaceutical companies and member states. Read more
 
 
 
   

From our blog
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 

110811 Visualizing the HPV vaccine
11 August 2011 - Richard Bergström

Richard Bergström tells us about a blog, written by David McCandless, on how designed information can help us understand... Read more

130502 The HIV Story: When Research Faces Setbacks, Look to Previous Advances for Inspiration...
02 May 2013 - Richard Bergström

Richard Bergström discusses the third meeting of the International HIV Treatment as Prevention Workshop Read more
 
 
 
   

Video
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
Test video title
President Obama congratulates you for everything your generation has done to change the planet. But now it’s showtime.... Read more
 
 
 
   

Events
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 

A Roadmap for Sharing Clinical Trial Data
27 August 2013 (Brussels)

... Read more

161216 Save the Date: 5th EMA-EBE Regulatory Policy Seminar - "Optimising ATMP development...
16 December 2016 (London, UK)

... Read more

160406 DIA 28th Annual EuroMeeting 2016
06 April 2016 (Hamburg, Germany )

A platform to exchange ideas on key challenges facing healthcare Read more
 
 
 
   

Documents
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
 
 
   

What we are reading
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
Lasers Measure Cells’ Stiffness to Identify Neoplastic Ones
On 01 March 2017 (www.medgadget.com)

... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2025 All rights reserved Disclaimer